INSTITUT PASTEUR DE TUNIS
6Patents
4Active
6Granted
36Portfolio score
Filing activity: Dec 12, 2003 → May 29, 2019 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11191807B2 | Lebecetin, a C-type lectin, as neovascularization inhibitor | Chemistry; Metallurgy | 0 | Active |
| US7888492B2 | Polypeptides of Leishmania major and polynucleotides encoding same and vaccinal, therapeutical and diagnostic applications thereof | Emerging Cross-Sectional Technologies | 0 | Expired |
| US7700121B2 | Gene associated with leishmania parasite virulence | Emerging Cross-Sectional Technologies | 0 | Expired |
| US11559575B2 | Multi-epitopic peptide compounds and vaccines against leishmaniasis | Emerging Cross-Sectional Technologies | 0 | Active |
| US8715697B2 | Genes associated with Leishmania parasite virulence | Emerging Cross-Sectional Technologies | 0 | Active |
| US8551500B2 | Composition comprising the N-terminal region of histone H2B of leishmania—use thereof for inducing an immune response | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.